SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Align-Rite Int'l (MASK) Undervalued compared to PLAB DPMI -- Ignore unavailable to you. Want to Upgrade?

To: Donald Wennerstrom who wrote (332)5/24/1999 1:35:00 AM
From: Carl R.  Respond to of 388
 
Yep. MASK is clearly undervalued. The only question is whether or not they are doomed to stay that way. <G>

I continue to hold MASK.

Carl



To: Donald Wennerstrom who wrote (332)5/24/1999 1:56:00 AM
From: Douglas V. Fant  Read Replies (3) | Respond to of 388
 
Donald, Good analysis! We'll see if MASK can "break the pattern" of consistent undervaluation. As Warren Buffett said, short-term the market is a voting mechanism (popularity), and long-term a weighing mechanism (economic underpinnings)...

Also take a look at UCOR for a similarly undervalued (IMO) biotech stock...



To: Donald Wennerstrom who wrote (332)9/20/1999 2:37:00 PM
From: DGMontana  Read Replies (2) | Respond to of 388
 
I write as one who reads often, but stays mostly silent: is MASK holding around $19/share because of the inevitable uncertainty that surrounds M & A? If MASK holders are being offered $23/share of PLAB, why hasn't MASK risen closer to this level? Why is this not simply easy money sitting on the table? Thanks in advance.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News